Obsidian Therapeutics Stock

obsidiantx.comHealthcare / BioTech & PharmaFounded: 2015

Obsidian Therapeutics is a clinical-stage biotechnology specializing in engineered cell and gene therapies with a mission to deliver transformative outcomes for patients with intractable diseases. The company utilizes drug-responsive domains for controlled protein function in therapeutics, aiming for targeted treatment solutions. Obsidian Therapeutics was founded by Michael Gilman, Steve Shamah, and Tariq Kassum in 2015 and is headquartered in Cambridge, MA.

Register To Buy and Sell Shares

For more details on financing and valuation for Obsidian Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Obsidian Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Obsidian Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Obsidian Therapeutics investors also invested in these private companies


Management Team

Thomas Wandless Ph.D
Scientific Co-Founder
Jeffrey Trigilio
Chief Financial Officer

Frequently Asked Questions About Obsidian Therapeutics’ Stock

Can you buy Obsidian Therapeutics’ stock?
Obsidian Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Obsidian Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Obsidian Therapeutics’ stock?
Yes, you can sell stock of a private company like Obsidian Therapeutics. Forge can help you sell your Obsidian Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Obsidian Therapeutics’ stock price?
Obsidian Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Obsidian Therapeutics’ private market stock price with Forge Data.
What is Obsidian Therapeutics’ stock ticker symbol?
Obsidian Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Obsidian Therapeutics Raises $160.5M in Series C Funding
In a series C funding round led by Wellington Management, Obsidian raised $160.5 million.
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.